Robeco Institutional Asset Management
CRL icon

Robeco Institutional Asset Management’s Charles River Laboratories CRL Stock Holding History

Robeco Institutional Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,354
Closed -$804K – 907
2024
Q4 		$804K Buy
4,354
+126
+3% +$24.3K ﹤0.01% 802
2024
Q3 		$833K Sell
4,228
-1,107
-21% -$230K ﹤0.01% 796
2024
Q2 		$1.1M Sell
5,335
-773
-13% -$175K ﹤0.01% 760
2024
Q1 		$1.65M Buy
6,108
+2,758
+82% +$659K ﹤0.01% 717
2023
Q4 		$792K Buy
3,350
+2,700
+415% +$531K ﹤0.01% 801
2023
Q3 		$127K Sell
650
-101
-13% -$20.7K ﹤0.01% 950
2023
Q2 		$158K Buy
751
+276
+58% +$54.9K ﹤0.01% 955
2023
Q1 		$95.9K Buy
+475
New +$108K ﹤0.01% 980
2022
Q4 		– Sell
-475
Closed -$94K – 965
2022
Q3 		$94K Sell
475
-3,904
-89% -$843K ﹤0.01% 884
2022
Q2 		$938K Sell
4,379
-5,623
-56% -$1.37M ﹤0.01% 706
2022
Q1 		$2.84M Sell
10,002
-10,506
-51% -$3.24M 0.01% 614
2021
Q4 		$7.73M Sell
20,508
-110
-0.5% -$42.7K 0.02% 488
2021
Q3 		$8.51M Buy
20,618
+6,125
+42% +$2.54M 0.02% 485
2021
Q2 		$5.36M Buy
+14,493
New +$4.84M 0.01% 569

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Robeco Institutional Asset Management's CRL Position: Q1 2025 in Review

Robeco Institutional Asset Management sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 4,354 shares — an estimated $804K sold.

Robeco Institutional Asset Management first reported a position in CRL in Q2 2021 and held it in 14 quarters. The position peaked at $8.51M in Q3 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Robeco Institutional Asset Management reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 4,354 Charles River Laboratories shares in Q1 2025, an estimated $804K.
  • Robeco Institutional Asset Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 14 quarters.
  • Robeco Institutional Asset Management's Charles River Laboratories position peaked at $8.51M in Q3 2021.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.